Mankind Pharma [MANKIND] vs Dr. Reddy's [DRREDDY] Detailed Stock Comparison

Mankind Pharma

NSE
Loading...

Dr. Reddy's

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Mankind Pharma wins in 5 metrics, Dr. Reddy's wins in 15 metrics, with 0 ties. Dr. Reddy's appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricMankind PharmaDr. Reddy'sBetter
P/E Ratio (TTM)54.9518.64Dr. Reddy's
Price-to-Book Ratio7.343.02Dr. Reddy's
Debt-to-Equity Ratio58.4313.75Dr. Reddy's
PEG Ratio-2.669.68Mankind Pharma
EV/EBITDA35.9111.65Dr. Reddy's
Profit Margin (TTM)14.66%16.99%Dr. Reddy's
Operating Margin (TTM)17.59%20.50%Dr. Reddy's
EBITDA Margin (TTM)17.59%20.50%Dr. Reddy's
Return on Equity13.67%17.71%Dr. Reddy's
Return on Assets (TTM)7.17%9.71%Dr. Reddy's
Free Cash Flow (TTM)$18.83B$12.03BMankind Pharma
Dividend Yield0.04%11.59%Dr. Reddy's
1-Year Return3.23%-4.16%Mankind Pharma
Price-to-Sales Ratio (TTM)8.163.16Dr. Reddy's
Enterprise Value$1,114.55B$1,041.18BMankind Pharma
EV/Revenue Ratio8.633.12Dr. Reddy's
Gross Profit Margin (TTM)70.49%56.91%Mankind Pharma
Revenue per Share (TTM)$317$401Dr. Reddy's
Earnings per Share (Diluted)$46.42$68.10Dr. Reddy's
Beta (Stock Volatility)0.350.32Dr. Reddy's
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Mankind Pharma vs Dr. Reddy's Stock Performance Analysis

Loading Price Chart...

Mankind Pharma
Dr. Reddy's
Mankind Pharma Stock Overview | Dr. Reddy's Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Mankind Pharma0.38%2.32%4.55%9.45%14.17%-10.47%
Dr. Reddy's3.25%-2.20%3.33%-5.11%11.74%-8.57%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Mankind Pharma3.23%84.98%84.98%84.98%84.98%84.98%
Dr. Reddy's-4.16%56.56%19.69%59.35%332.25%1,494.08%

News Based Sentiment: Mankind Pharma vs Dr. Reddy's

Mankind Pharma

News based Sentiment: MIXED

The month presented a mixed picture for Mankind Pharma, with positive analyst ratings and active investor engagement offset by a slight share price decline and a high valuation premium. While the company is making strategic moves to incentivize employees and improve transparency, investors should carefully consider the valuation and potential risks.

View Mankind Pharma News Sentiment Analysis

Dr. Reddy's

News based Sentiment: MIXED

The month presented a blend of positive and negative developments for Dr. Reddy's Laboratories, including regulatory approvals, financial improvements in a subsidiary, and partnership milestones, but also analyst downgrades, market weakness, and FDA observations. This creates a mixed investment narrative.

View Dr. Reddy's News Sentiment Analysis

Performance & Financial Health Analysis: Mankind Pharma vs Dr. Reddy's

MetricMANKINDDRREDDY
Market Information
Market Cap i₹1.05T₹1.06T
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i369,7921,421,840
90 Day Avg. Volume i511,7871,462,615
Last Close₹2,589.30₹1,291.30
52 Week Range₹2,132.00 - ₹3,054.80₹1,020.00 - ₹1,405.90
% from 52W High-15.24%-8.15%
All-Time High₹3,054.80 (Dec 23, 2024)₹1,421.49 (Aug 19, 2024)
% from All-Time High-15.24%-9.16%
Growth Metrics
Quarterly Revenue Growth0.23%0.11%
Quarterly Earnings Growth-0.18%0.02%
Financial Health
Profit Margin (TTM) i0.15%0.17%
Operating Margin (TTM) i0.18%0.21%
Return on Equity (TTM) i0.14%0.18%
Debt to Equity (MRQ) i58.4313.75
Cash & Liquidity
Book Value per Share (MRQ)₹347.39₹420.56
Cash per Share (MRQ)₹61.20₹80.12
Operating Cash Flow (TTM) i₹26.50B₹52.56B
Levered Free Cash Flow (TTM) i₹19.91B₹14.23B
Dividends
Last 12-Month Dividend Yield i0.04%11.59%
Last 12-Month Dividend i₹1.00₹146.30

Valuation & Enterprise Metrics Analysis: Mankind Pharma vs Dr. Reddy's

MetricMANKINDDRREDDY
Price Ratios
P/E Ratio (TTM) i54.9518.64
Forward P/E i41.343.70
PEG Ratio i-2.669.68
Price to Sales (TTM) i8.163.16
Price to Book (MRQ) i7.343.02
Market Capitalization
Market Capitalization i₹1.05T₹1.06T
Enterprise Value i₹1.11T₹1.04T
Enterprise Value Metrics
Enterprise to Revenue i8.633.12
Enterprise to EBITDA i35.9111.65
Risk & Other Metrics
Beta i0.350.32
Book Value per Share (MRQ) i₹347.39₹420.56

Financial Statements Comparison: Mankind Pharma vs Dr. Reddy's

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)MANKINDDRREDDY
Revenue/Sales i₹35.70B₹85.45B
Cost of Goods Sold i₹10.54B₹36.83B
Gross Profit i₹25.17B₹48.63B
Research & Development iN/A₹6.24B
Operating Income (EBIT) i₹6.28B₹16.84B
EBITDA i₹9.30B₹23.41B
Pre-Tax Income i₹5.40B₹19.05B
Income Tax i₹958.70M₹4.95B
Net Income (Profit) i₹4.45B₹14.10B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)MANKINDDRREDDY
Cash & Equivalents i₹4.07B₹14.65B
Total Current Assets i₹69.88B₹250.11B
Total Current Liabilities i₹56.64B₹130.39B
Long-Term Debt i₹55.40B₹7.86B
Total Shareholders Equity i₹145.68B₹337.17B
Retained Earnings i₹119.07B₹315.79B
Property, Plant & Equipment i₹29.08B₹0

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)MANKINDDRREDDY
Operating Cash Flow i₹3.41B₹27.79B
Capital Expenditures i₹-1.30B₹-7.67B
Free Cash Flow i₹3.51B₹10.75B
Debt Repayment i₹-191.39M₹-253.00M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricMANKINDDRREDDY
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i369,7921,421,840
Average Daily Volume (90 Day) i511,7871,462,615
Shares Outstanding i412.58M832.00M
Float Shares i106.01M591.37M
% Held by Insiders i0.74%0.29%
% Held by Institutions i0.18%0.52%

Dividend Analysis & Yield Comparison: Mankind Pharma vs Dr. Reddy's

MetricMANKINDDRREDDY
Last 12-Month Dividend i₹1.00₹146.30
Last 12-Month Dividend Yield i0.04%11.59%
3-Year Avg Annual Dividend i₹0.33₹49.30
3-Year Avg Dividend Yield i0.04%3.74%
3-Year Total Dividends i₹1.00₹147.90
Ex-Dividend DateAug 08, 2025Jul 10, 2025